University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2005-06-14
- Last Posted Date
- 2009-11-26
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 48
- Registration Number
- NCT00114153
- Locations
- 🇺🇸
University of Virginia Cancer Center at UV Health System, Charlottesville, Virginia, United States
Modafinil in Treating Fatigue in Patients With Cancer
Not Applicable
- Conditions
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2009-08-20
- Lead Sponsor
- University of Virginia
- Registration Number
- NCT00112515
- Locations
- 🇺🇸
University of Virginia Cancer Center, Charlottesville, Virginia, United States
Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2004-09-09
- Last Posted Date
- 2014-06-20
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 9
- Registration Number
- NCT00091273
- Locations
- 🇺🇸
University of Virginia Cancer Center, Charlottesville, Virginia, United States
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-08-25
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 22
- Registration Number
- NCT00003224
- Locations
- 🇺🇸
Cancer Center, University of Virginia HSC, Charlottesville, Virginia, United States
Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2014-11-20
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 39
- Registration Number
- NCT00089219
- Locations
- 🇺🇸
University of Virginia Cancer Center, Charlottesville, Virginia, United States
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Phase 2
Completed
- Conditions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 7
- Registration Number
- NCT00089206
- Locations
- 🇺🇸
Cancer Center at the University of Virginia, Charlottesville, Virginia, United States
Vaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma
- First Posted Date
- 2004-02-09
- Last Posted Date
- 2014-12-19
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 40
- Registration Number
- NCT00003222
- Locations
- 🇺🇸
Cancer Center at the University of Virginia, Charlottesville, Virginia, United States
Internet-based Treatment of Early Childhood Fecal Incontinence
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2003-08-28
- Last Posted Date
- 2015-12-07
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 91
- Registration Number
- NCT00067769
- Locations
- 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States
© Copyright 2024. All Rights Reserved by MedPath